Ra Capital Management as of Sept. 30, 2016
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 30 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences (WVE) | 23.4 | $230M | 7.1M | 32.47 | |
| Achillion Pharmaceuticals | 9.9 | $98M | 12M | 8.10 | |
| Ascendis Pharma A S (ASND) | 7.5 | $74M | 3.7M | 20.10 | |
| Avexis | 7.3 | $71M | 1.7M | 41.21 | |
| Axovant Sciences | 7.1 | $70M | 5.0M | 14.00 | |
| Nektar Therapeutics (NKTR) | 6.4 | $63M | 3.7M | 17.18 | |
| Zogenix | 4.5 | $45M | 2.7M | 16.75 | |
| Ardelyx (ARDX) | 4.3 | $42M | 3.3M | 12.94 | |
| Aclaris Therapeutics (ACRS) | 4.0 | $40M | 1.5M | 25.61 | |
| Tg Therapeutics (TGTX) | 3.6 | $36M | 4.6M | 7.74 | |
| Aquinox Pharmaceuticals | 3.0 | $29M | 2.2M | 13.36 | |
| Aimmune Therapeutics | 2.0 | $19M | 1.3M | 15.00 | |
| Foamix Pharmaceuticals | 1.7 | $17M | 1.8M | 9.26 | |
| Protagonist Therapeutics (PTGX) | 1.6 | $16M | 754k | 21.13 | |
| Proteon Therapeutics | 1.6 | $15M | 1.6M | 9.33 | |
| Dicerna Pharmaceuticals | 1.4 | $14M | 2.4M | 5.88 | |
| BioCryst Pharmaceuticals (BCRX) | 1.3 | $13M | 3.0M | 4.41 | |
| Strongbridge Bioph shs usd | 1.3 | $13M | 2.5M | 5.22 | |
| Audentes Therapeutics | 1.3 | $13M | 707k | 17.81 | |
| Dimension Therapeutics | 1.3 | $12M | 1.5M | 7.99 | |
| Acceleron Pharma | 1.2 | $12M | 319k | 36.19 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.1 | $11M | 1.5M | 7.35 | |
| Tenax Therapeutics | 0.6 | $5.5M | 2.4M | 2.31 | |
| Beigene (BGNE) | 0.5 | $5.2M | 170k | 30.81 | |
| Alcobra | 0.5 | $5.1M | 2.0M | 2.47 | |
| Eiger Biopharmaceuticals | 0.5 | $4.7M | 354k | 13.39 | |
| Sangamo Biosciences (SGMO) | 0.4 | $4.2M | 899k | 4.63 | |
| Aeglea Biotherapeutics | 0.2 | $2.2M | 336k | 6.41 | |
| Arca Biopharma | 0.1 | $1.5M | 522k | 2.83 | |
| Akari Therapeutics | 0.1 | $971k | 114k | 8.51 |
